THE ALKALINE PROTEASE OF ASPERGILLUS-FUMIGATUS IS NOT A VIRULENCE DETERMINANT IN 2 MURINE MODELS OF INVASIVE PULMONARY ASPERGILLOSIS

被引:116
|
作者
TANG, CM
COHEN, J
KRAUSZ, T
VANNOORDEN, S
HOLDEN, DW
机构
[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT INFECT DIS & BACTERIOL, DU CANE RD, LONDON W12 0NN, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT HISTOPATHOL, LONDON W12 0NN, ENGLAND
关键词
D O I
10.1128/IAI.61.5.1650-1656.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known of the pathophysiology of invasive pulmonary aspergillosis (IPA), an opportunistic fungal infection usually caused by Aspergillus fumigatus. It has been suggested that the ability of the fungus to degrade elastin may aid its invasion and growth in lung tissue. We have described previously the construction of a strain of A. fumigatus in which the gene encoding an alkaline protease, AFAlp, had been disrupted (C. M. Tang, J. Cohen, and D. W. Holden, Mol. Microbiol. 6:1663-1671, 1992); this mutant is deficient in extracellular proteolytic and elastinolytic activity over a broad pH range. In this study, we compared the pathogenicity of this and another AFAlp disruptant with their isogenic, elastase-producing parental strains in two murine models of IPA. In both models, animals were inoculated via the respiratory tract. In the first model, the inoculum was delivered as airborne conidia and animals developed signs of respiratory distress within 2 to 4 days. In the second model, conidia were administered intranasally as a suspension and the disease developed over a 2-week period. No difference was observed between the wild-type and AFAlp disruptants in terms of mortality, and elastin breakdown was detected in lung tissue from animals inoculated with all four strains. We conclude that AFAlP is not a virulence determinant in these models of IPA.
引用
收藏
页码:1650 / 1656
页数:7
相关论文
共 50 条
  • [41] Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species
    Cho, Sung-Yeon
    Lee, Dong-Gun
    Choi, Jae-Ki
    Lee, Hyo-Jin
    Kim, Si-Hyun
    Park, Sun Hee
    Choi, Su-Mi
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    Park, Yeon-Joon
    Lee, Jong-Wook
    MEDICINE, 2017, 96 (49)
  • [42] Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis
    Yao, Yake
    Zhou, Hua
    Shen, Yihong
    Yang, Qing
    Ye, Jian
    Lu, Guohua
    Fu, Yiqi
    Lou, Haiyan
    Yu, Yunsong
    Zhou, Jianying
    MEDICINE, 2017, 96 (51)
  • [43] Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection
    Nawada, R
    Amitani, R
    Tanaka, E
    Niimi, A
    Suzuki, K
    Murayama, T
    Kuze, F
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) : 1433 - 1439
  • [44] Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis:: Implications for antifungal therapy
    Hope, William W.
    Kruhlak, Michael J.
    Lyman, Caron A.
    Petraitiene, Ruta
    Petraitis, Vidmantas
    Francesconi, Andrea
    Kasai, Miki
    Mickiene, Diana
    Sein, Tin
    Peter, Joanne
    Kelaher, Amy M.
    Hughes, Johanna E.
    Cotton, Margaret P.
    Cotten, Catherine J.
    Bacher, John
    Tripathi, Sanjay
    Bermudez, Louis
    Maugel, Timothy K.
    Zerfas, Patricia M.
    Wingard, John R.
    Drusano, George L.
    Walsh, Thomas J.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (03): : 455 - 466
  • [46] Epidemiological characteristics of patients with invasive pulmonary aspergillosis infected with Aspergillus fumigatus from a tertiary hospital in Ningxia, China
    Yuting Kang
    Qiujie Li
    Wanting Ma
    Chao Xu
    Wei Jia
    Pengtao Wang
    Scientific Reports, 15 (1)
  • [47] Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis
    Jeans, Adam R.
    Howard, Susan J.
    Al-Nakeeb, Zaid
    Goodwin, Joanne
    Gregson, Lea
    Warn, Peter A.
    Hope, William W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) : 5180 - 5185
  • [48] Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
    Rayens, Emily
    Rabacal, Whitney
    Kang, S. Earl
    Celia, Brandi N.
    Momany, Michelle
    Norris, Karen A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus
    Menotti, J
    Waller, J
    Meunier, O
    Letscher-Bru, V
    Herbrecht, R
    Candolfi, E
    JOURNAL OF HOSPITAL INFECTION, 2005, 60 (01) : 61 - 68
  • [50] Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis
    Lewis, Russell E.
    Albert, Nathaniel D.
    Kontoyiannis, Dimitrios P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6767 - 6772